We are live on
!
Find out more
MLICM
Metropolitan Life Insurance Company (MetLife) Portfolio holdings
AUM
$328M
1-Year Est. Return
9.77%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$7.53B
AUM Growth
-$8.45B
(-53%)
Cap. Flow
-$9.27B
Cap. Flow
% of AUM
-123.16%
Top 10 Holdings %
Top 10 Hldgs %
33.43%
Holding
2,587
New
127
Increased
54
Reduced
2,293
Closed
88
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$11.4M |
| 2 |
American Electric Power
AEP
|
+$5.7M |
| 3 |
BPMP
BP Midstream Partners LP Common Units representing Limited Partner Interests
BPMP
|
+$4.35M |
| 4 |
Clorox
CLX
|
+$3.38M |
| 5 |
KLA
KLAC
|
+$3.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$277M |
| 2 |
Bank of America
BAC
|
+$216M |
| 3 |
Microsoft
MSFT
|
+$202M |
| 4 |
Amazon
AMZN
|
+$140M |
| 5 |
Meta Platforms (Facebook)
META
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.11% |
| 2 | Technology | 11.55% |
| 3 | Healthcare | 8.57% |
| 4 | Industrials | 7.86% |
| 5 | Consumer Discretionary | 6.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
LivePerson
LPSN
$35.9M
| $170K | ﹤0.01% |
984
-1,755
| -64% | -$329K |
|
2002
NeoGenomics
NEO
$2.11B
| $170K | ﹤0.01% |
19,141
-18,291
| -49% | -$169K |
|
2003
Peoples Bancorp
PEBO
$1.49B
| $170K | ﹤0.01% |
5,206
-4,557
| -47% | -$152K |
|
|
LION
2004
DELISTED
Fidelity Southern Corporation
LION
| $170K | ﹤0.01% |
7,818
-8,215
| -51% | -$181K |
|
2005
Agios Pharmaceuticals
AGIO
$2B
| $169K | ﹤0.01% |
2,957
-32
| -1% | -$2.01K |
|
|
CHUY
2006
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $169K | ﹤0.01% |
6,012
-6,115
| -50% | -$145K |
|
|
CORR
2007
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $169K | ﹤0.01% |
4,412
-4,445
| -50% | -$161K |
|
|
REGI
2008
DELISTED
Renewable Energy Group, Inc.
REGI
| $169K | ﹤0.01% |
14,326
-17,445
| -55% | -$202K |
|
2009
Atara Biotherapeutics
ATRA
$76.7M
| $168K | ﹤0.01% |
371
-338
| -48% | -$125K |
|
2010
REX American Resources
REX
$1.44B
| $168K | ﹤0.01% |
12,144
-13,182
| -52% | -$193K |
|
|
SHYF
2011
DELISTED
The Shyft Group
SHYF
| $168K | ﹤0.01% |
10,665
-14,795
| -58% | -$225K |
|
2012
Virtu Financial
VIRT
$5.05B
| $168K | ﹤0.01% |
9,171
-9,939
| -52% | -$161K |
|
|
AMAG
2013
DELISTED
AMAG Pharmaceuticals
AMAG
| $168K | ﹤0.01% |
12,656
-11,484
| -48% | -$173K |
|
|
HTB
2014
HomeTrust Bancshares
HTB
$837M
| $167K | ﹤0.01% |
6,473
-4,297
| -40% | -$113K |
|
2015
Ingersoll Rand
IR
$32.7B
| $165K | ﹤0.01% |
4,850
+1,620
| +50% | +$48.3K |
|
2016
Marcus Corp
MCS
$929M
| $165K | ﹤0.01% |
6,047
-7,669
| -56% | -$211K |
|
2017
QCR Holdings
QCRH
$1.75B
| $165K | ﹤0.01% |
3,855
-4,882
| -56% | -$223K |
|
|
UMH
2018
UMH Properties
UMH
$1.42B
| $165K | ﹤0.01% |
11,052
-10,790
| -49% | -$164K |
|
|
ZAGG
2019
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $165K | ﹤0.01% |
8,938
-11,362
| -56% | -$213K |
|
|
CNCE
2020
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $164K | ﹤0.01% |
+6,348
| New | +$128K |
|
|
ACTA
2021
DELISTED
Actua Corp
ACTA
| $164K | ﹤0.01% |
10,498
-9,631
| -48% | -$150K |
|
2022
Ezcorp Inc
EZPW
$1.76B
| $163K | ﹤0.01% |
13,358
-23,204
| -63% | -$253K |
|
2023
Ingles Markets
IMKTA
$1.68B
| $163K | ﹤0.01% |
4,706
-4,337
| -48% | -$118K |
|
|
FRGI
2024
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $163K | ﹤0.01% |
8,592
-10,788
| -56% | -$194K |
|
|
FINL
2025
DELISTED
Finish Line
FINL
| $163K | ﹤0.01% |
11,219
-16,731
| -60% | -$180K |
|
Similar funds
GWM
KSCM
AFS
BAM
ML
BCM
ECH
PCM
Metropolitan Life Insurance Company (MetLife)'s Q4 2017 Portfolio in Review
As of Q4 2017, Metropolitan Life Insurance Company (MetLife) held 2,587 positions worth $7.53B, down 53% from $16B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Metropolitan Life Insurance Company (MetLife) withdrew a net $9.27B in Q4 2017, closing 88 positions and reducing 2,293 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $89.8M position sold in full.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 23% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in CVS Health worth $11.4M.
- Metropolitan Life Insurance Company (MetLife)'s largest Q4 2017 buy was CVS Health: 157,105 shares worth $11.4M.
- Metropolitan Life Insurance Company (MetLife) added most to iShares National Muni Bond ETF in Q4 2017, an estimated $3M increase.
- Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2017 reduction was Apple, cutting an estimated $277M.
- Metropolitan Life Insurance Company (MetLife) fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2017, selling an estimated $89.8M.
- Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 33% of its $7.53B portfolio in Q4 2017.
- Metropolitan Life Insurance Company (MetLife) opened 127 new positions and closed 88 in Q4 2017.
- Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 53% quarter-over-quarter to $7.53B.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.